Smith T - Search Results

1

A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanoma.

Bedikian AY, Plager C, Papadopoulos N, Ellerhorst J, Smith T, Benjamin RS. Bedikian AY, et al. Among authors: smith t. Oncol Rep. 2000 Jul-Aug;7(4):883-6. doi: 10.3892/or.7.4.883. Oncol Rep. 2000. PMID: 10854563 Clinical Trial.

2

A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.

Bedikian AY, Papadopoulos NE, Kim KB, Vardeleon A, Smith T, Lu B, Deitcher SR. Bedikian AY, et al. Among authors: smith t. Melanoma Res. 2008 Dec;18(6):400-4. doi: 10.1097/CMR.0b013e328311aaa1. Melanoma Res. 2008. PMID: 19011511 Clinical Trial.

3

Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma.

Ellerhorst JA, Bedikian AY, Smith TM, Papadopoulos NE, Plager C, Eton O. Ellerhorst JA, et al. Anticancer Drugs. 2002 Feb;13(2):169-72. doi: 10.1097/00001813-200202000-00009. Anticancer Drugs. 2002. PMID: 11901310 Clinical Trial.

4

A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy.

Eton O, Buzaid AC, Bedikian AY, Smith TM, Papadopoulos NE, Ellerhorst JA, Hibberts JL, Legha SS, Benjamin RS. Eton O, et al. Among authors: smith tm. Cancer. 2000 Apr 1;88(7):1703-9. Cancer. 2000. PMID: 10738230 Clinical Trial.

5

Phase II evaluation of bryostatin-1 in metastatic melanoma.

Bedikian AY, Plager C, Stewart JR, O'Brian CA, Herdman SK, Ross M, Papadopoulos N, Eton O, Ellerhorst J, Smith T. Bedikian AY, et al. Among authors: smith t. Melanoma Res. 2001 Apr;11(2):183-8. doi: 10.1097/00008390-200104000-00014. Melanoma Res. 2001. PMID: 11333129 Clinical Trial.

6

Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.

Bedikian AY, Vardeleon A, Smith T, Campbell S, Namdari R. Bedikian AY, et al. Among authors: smith t. J Clin Pharmacol. 2006 Jul;46(7):727-37. doi: 10.1177/0091270006288953. J Clin Pharmacol. 2006. PMID: 16809798 Clinical Trial.

7

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.

Logothetis CJ, Finn LD, Smith T, Kilbourn RG, Ellerhorst JA, Zukiwski AA, Sella A, Tu SM, Amato RJ. Logothetis CJ, et al. Among authors: smith t. J Clin Oncol. 1995 Sep;13(9):2272-7. doi: 10.1200/JCO.1995.13.9.2272. J Clin Oncol. 1995. PMID: 7666085 Clinical Trial.

8

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma.

Pagliaro L, Daliani D, Amato R, Tu SM, Jones D, Smith T, Logothetis C, Millikan R. Pagliaro L, et al. Among authors: smith t. Cancer. 2000 Aug 1;89(3):615-8. Cancer. 2000. PMID: 10931461 Clinical Trial.

9

Determinants of prognosis in late chronic-phase chronic myelogenous leukemia.

Rodriguez J, Cortes J, Smith T, O'Brien S, Rios MB, Talpaz M, Kantarjian H. Rodriguez J, et al. Among authors: smith t. J Clin Oncol. 1998 Dec;16(12):3782-7. doi: 10.1200/JCO.1998.16.12.3782. J Clin Oncol. 1998. PMID: 9850022

10

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN. Dhingra K, et al. Among authors: smith t. Clin Cancer Res. 1995 Jul;1(7):691-7. Clin Cancer Res. 1995. PMID: 9816034 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,437 results

Search Page

Filters